Ontology highlight
ABSTRACT:
SUBMITTER: Strickler JH
PROVIDER: S-EPMC3336830 | biostudies-other | 2012
REPOSITORIES: biostudies-other
The oncologist 20120403 4
Since its approval for the first-line treatment of metastatic colorectal cancer (mCRC), bevacizumab has become a standard treatment option in combination with chemotherapy for patients with mCRC. Bevacizumab has demonstrated efficacy in combination with a number of different backbone chemotherapy regimens, and its widespread use has introduced several important questions regarding the selection and optimization of bevacizumab-based treatment regimens, its use in various patient populations, and ...[more]